Madrigal Pharmaceuticals Inc (MDGL)

Total Costs & Expenses

$1.61B

TTM · Period ending: · USD

MDGL logo

MDGL Total Costs & Expenses

Latest reported$1.61B
MDGL TTM Total Costs & Expenses (-$50.37M → $1.61B)
High-resolution chart · PNG

MDGL total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Madrigal Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
1,606,555,000
1,445,999,000
1,258,500,000
1,048,124,000
825,360,000
742,531,000
678,007,000
624,867,000
544,922,000
454,197,000
380,496,000
348,619,000
330,497,000
314,320,000
293,571,000
272,873,000
255,621,000
247,090,000
242,482,000
237,436,000
233,062,000
221,647,000
206,673,000
177,072,000
142,481,000
114,858,000
94,972,000
79,472,000
66,610,000
51,732,000
40,682,000
35,139,000
32,443,000
33,056,000
32,062,000
30,907,000
36,361,000
31,411,000
31,783,000
34,407,000
37,710,000
53,725,000
67,610,000
77,124,000
79,179,000
81,376,000
83,951,000
87,501,000
89,846,000
90,208,000
87,559,000
81,818,000
74,563,000
66,634,000
61,088,000
57,047,000
56,390,000
55,619,000
53,016,000
51,756,000
51,488,000
50,529,000
51,701,000
50,959,000
49,578,000
50,277,000
63,705,000
78,546,000
94,036,000
105,218,000
98,292,000
88,877,000
76,548,000
69,729,000
66,958,000
62,877,000
62,060,000
29,666,000
-2,274,000
-30,771,000
-72,034,000
-83,792,000
-50,366,000
-25,732,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.